Access Neumora Stock and Financial Details

Neumora Funding Rounds and Valuation

Funding History Chart

Funding Round Details

	Funding Date	Share Class	Amount Raised	Price per Share	Post-Money Valuation	Key Investors
	10/11/2022	Series B	$112.4MM	$xx.xx	$1.33B	Abu Dhabi Growth Fund, Altitude Life Science Ventures, Amgen, Arch Venture Partners, Exor Ventures, F-Prime Capital, Invus, Mubadala Capital, Newpath Partners, Polaris Partners
Price per Share $xx.xx Shares Outstanding 74,930,001 Liquidation Pref Order 1 Liquidation Pref As Multiplier 1.0x Conversion Ratio 1.0x Dividend Rate 6.0% Cumulative Non-cumulative Participating Non-participating Participation Cap -- Key Investors Abu Dhabi Growth Fund, Altitude Life Science Ventures, Amgen, Arch Venture Partners, Exor Ventures, F-Prime Capital, Invus, Mubadala Capital, Newpath Partners, Polaris Partners
	10/07/2021	Series A-1	$31.84MM	$xx.xx	$909.09MM	Alexandria Venture Investments, Altitude Life Science Ventures, Amgen, Arch Venture Partners, Catalio Capital Management, F-Prime Capital, Invus, Logos Capital, Mubadala Capital, Newpath Partners, Polaris Partners, Re.Mind Capital, Softbank, Surveyor Capital, Waycross Ventures
Price per Share $xx.xx Shares Outstanding 31,841,938 Liquidation Pref Order 2 Liquidation Pref As Multiplier 1.0x Conversion Ratio 1.0x Dividend Rate 6.0% Cumulative Non-cumulative Participating Non-participating Participation Cap -- Key Investors Alexandria Venture Investments, Altitude Life Science Ventures, Amgen, Arch Venture Partners, Catalio Capital Management, F-Prime Capital, Invus, Logos Capital, Mubadala Capital, Newpath Partners, Polaris Partners, Re.Mind Capital, Softbank, Surveyor Capital, Waycross Ventures
	10/07/2021	Series A-2	$468.16MM	$xx.xx	$909.09MM	Alexandria Venture Investments, Altitude Life Science Ventures, Amgen, Arch Venture Partners, Catalio Capital Management, F-Prime Capital, Invus, Logos Capital, Mubadala Capital, Newpath Partners, Polaris Partners, Re.Mind Capital, Softbank, Surveyor Capital, Waycross Ventures
Price per Share $xx.xx Shares Outstanding 468,158,062 Liquidation Pref Order 1 Liquidation Pref As Multiplier 1.0x Conversion Ratio 1.0x Dividend Rate 6.0% Cumulative Non-cumulative Participating Non-participating Participation Cap -- Key Investors Alexandria Venture Investments, Altitude Life Science Ventures, Amgen, Arch Venture Partners, Catalio Capital Management, F-Prime Capital, Invus, Logos Capital, Mubadala Capital, Newpath Partners, Polaris Partners, Re.Mind Capital, Softbank, Surveyor Capital, Waycross Ventures

Access Stock Price

Neumora stock FAQs

Can you buy Neumora stock?

You can no longer buy Neumora stock on a secondary marketplace as this company is no longer private. If you are interested in buying stock of other private companies, learn more about how to invest in the private market or register today to get started.

How to buy Neumora stock?

Can you sell Neumora stock?

You can no longer sell stock of Neumora on Forge as this company is no longer private. However, if you own stock of a private company, Forge may help you sell it in a way that works for you and the company. Learn more or register with us today to get started.

How to sell Neumora stock?

Is Neumora a public company?

Neumora is now a public company traded on NASDAQ with ticker NMRA.

What is Neumora’s stock price?

The stock price of Neumora is $14.66 as of 1/18/24.

What is Neumora’s stock ticker symbol?

The ticker symbol of Neumora is NMRA.

Can institutional investors buy and sell private market stocks?

Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

Neumora’s News and Media Highlights

Blog

Instacart goes public, while Klaviyo, Turo, and Neumora provide fresh details about IPO plans

September 18, 2023

Four companies with plans to go public have provided investors with additional financial information about their eagerly-anticipated IPOs.

Reuters 09/11/2023

SoftBank-backed Neumora seeks $2.74 billion valuation in US IPO

Neumora Therapeutics, backed by Amgen (AMGN.O) and Japan's SoftBank (9984.T), is seeking a valuation of up to $2.74 billion in its U.S. initial public offering, as the biopharmaceutical company looks to ride a revival in stock market listings.

Business Wire 10/07/2021

Neumora Therapeutics Launches to Pioneer a New Era of Precision Medicines for Brain Diseases

Neumora Therapeutics, Inc. (Neumora), a clinical-stage biotechnology company pioneering precision medicines for brain diseases through the integration of data science and neuroscience, announced its launch today. Neumora was founded as a response to the lack of targeted, effective medicines for brain diseases and the high failure rate that has plagued neuroscience drug development for decades.

Browse Insights

Last Funding Round
AI Therapeutics	--	$xx.xx	--	--	--	--
Affinia Therapeutics	--	$xx.xx	Series B	$365.7MM	$xx.xx	$110MM
Altos Labs	--	$xx.xx	Series C	$6.33B	$xx.xx	$1.5B
ArsenalBio	--	$xx.xx	Series C	$1.66B	$xx.xx	$327.5MM
Be Biopharma	--	$xx.xx	Series B	$280.11MM	$xx.xx	$118MM
Colossal Biosciences	--	$xx.xx	Series B	$1.01B	$xx.xx	$150MM
Egenesis	--	$xx.xx	Series D	$332.59MM	$xx.xx	$90.96MM
Precision Neuroscience	--	$xx.xx	--	--	--	--
ReCode Therapeutics	--	$xx.xx	Series B	$582.08MM	$xx.xx	$274.8MM
Xaira Therapeutics	--	$xx.xx	Series A	$2.65B	$xx.xx	$500MM

Updated on: Nov 22, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

1. Forge Price™ is a custom data-point calculated and disseminated by Forge Data LLC (“Forge Data”) and is a mark of Forge Data. Forge Price may rely on a very limited number of inputs in its calculation. Forge Price is prepared and disseminated solely for informational purposes. Redistribution is permitted solely with Forge’s written consent. While Forge has obtained information from sources it believes to be reliable, Forge does not perform an audit or undertake any duty of due diligence or independent verification of any information it receives. Forge does not guarantee the accuracy, completeness, timeliness, or availability of Forge Price, and are not responsible for any errors or omissions, regardless of the cause, or any results obtained from the use of Forge Price. Forge Price is derived from secondary activity on the Forge platform and other private market trading platforms, and other publicly-available datapoints collected by Forge.  Forge Price is not intended to, and does not necessarily, represent the market price of any securities (I.e., the price at which you could buy or sell such securities). Neither reference to company names, nor calculation of Forge Price for a specific company, implies any affiliation between Forge and that company, any endorsement or sponsorship by Forge of any company or vice versa, or any partnership, joint venture or other commercial relationship between Forge and any company. Rights with respect to any company marks referred to herein are owned by the company.

2. The Last Closed Trade price displayed reflects the price at which the last trade in this company's security occurred on Forge, and can include secondary trades in any class of the company's security, or trades in units of funds holding the company's securities (the economics of which differ versus direct company ownership). The date displayed reflects the date on which the last trade in this company's security closed on Forge. This may be several weeks after the terms of the trade were agreed upon between the buyer and seller. In case of multiple trades closed on the same date, the price displayed is of either (i) the trade which terms were agreed upon most recently; or (ii) the trade with the higher notional value.

‘Stock Price’ or other private company metrics (‘PC Data’) may rely on a very limited number of trade and/or IOI inputs in their calculation. PC Data is prepared and disseminated solely for informational purposes. While Forge has obtained information from sources it believes to be reliable, Forge does not perform an audit or undertake any duty of due diligence or independent verification of any information it receives. Forge does not guarantee the accuracy, completeness, timeliness, or availability of PC Data, and are not responsible for any errors or omissions, regardless of the cause, or any results obtained from the use of PC Data. PC Data is derived from the performance and pricing of secondary activity on the Forge platform and other private market trading platforms. PC Data is not intended to, and does not necessarily, represent the market price of any securities (I.e., the price at which you could buy or sell such securities). Reference to company names does not imply any affiliation between Forge and that company, any endorsement or sponsorship by Forge of any company or vice versa, or any partnership, joint venture or other commercial relationship between Forge and any company. Rights with respect to any company marks referred to herein are owned by the company.

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.

Investing in private company securities is not suitable for all investors, is highly speculative, is high risk, and investors should be prepared to withstand a total loss of their investment. Private company securities are highly illiquid and there is no guarantee that a market will develop for such securities. Each investment carries its own risks, and investors should conduct their own due diligence regarding the investment, including obtaining independent professional advice. Past performance is not indicative of future results. This is not a recommendation, offer, solicitation of an offer, or advice to buy or sell securities by Forge, nor an offer of brokerage services in any jurisdiction where Forge is not permitted to offer brokerage services. Brokerage products and services are offered by Forge Securities LLC, a registered broker-dealer and member FINRA/SIPC. Please see other important disclaimers, disclosures and restrictions you acknowledge by using this website and to which you are subject.

Updated on: Nov 22, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Forge Price™ is a custom data-point calculated and disseminated by Forge Data LLC (“Forge Data”) and is a mark of Forge Data. Forge Price may rely on a very limited number of inputs in its calculation. Forge Price is prepared and disseminated solely for informational purposes. Redistribution is permitted solely with Forge’s written consent. While Forge has obtained information from sources it believes to be reliable, Forge does not perform an audit or undertake any duty of due diligence or independent verification of any information it receives. Forge does not guarantee the accuracy, completeness, timeliness, or availability of Forge Price, and are not responsible for any errors or omissions, regardless of the cause, or any results obtained from the use of Forge Price. Forge Price is derived from secondary activity on the Forge platform and other private market trading platforms, and other publicly-available datapoints collected by Forge. Forge Price is not intended to, and does not necessarily, represent the market price of any securities (I.e., the price at which you could buy or sell such securities). Neither reference to company names, nor calculation of Forge Price for a specific company, implies any affiliation between Forge and that company, any endorsement or sponsorship by Forge of any company or vice versa, or any partnership, joint venture or other commercial relationship between Forge and any company. Rights with respect to any company marks referred to herein are owned by the company.
The Last Closed Trade price displayed reflects the price at which the last trade in this company's security occurred on Forge, and can include secondary trades in any class of the company's security, or trades in units of funds holding the company's securities (the economics of which differ versus direct company ownership). The date displayed reflects the date on which the last trade in this company's security closed on Forge. This may be several weeks after the terms of the trade were agreed upon between the buyer and seller. In case of multiple trades closed on the same date, the price displayed is of either (i) the trade which terms were agreed upon most recently; or (ii) the trade with the higher notional value.
Post-Money Valuation represents the estimated valuation based on company-submitted Certificates of Incorporations (COIs).
Last Known Valuation represents a valuation gathered from non-COI, publicly available sources including company press releases or multiple concurring news articles.

Neumora Stock

Register To Buy and Sell Private Company Shares

Neumora Stock Price

Neumora Funding Rounds and Valuation